Related Experiment Videos
Apolipoprotein A and prognosis after myocardial infarction in non-diabetic men
H Pollak1, O Arnoldner, W Enenkel
1Medizinische Abteilung und Kardiologie, Krankenhaus der Stadt Wien-Lainz, Osterreich.
Insights
Apolipoprotein A-I and A-II levels do not predict future coronary events in men after myocardial infarction. These biomarkers did not differentiate patients who experienced subsequent cardiac events from those who did not.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Acute myocardial infarction (AMI) is a critical cardiovascular event.
- Prognostic markers for post-AMI patients are essential for risk stratification.
- Apolipoproteins A-I and A-II are key components of high-density lipoprotein (HDL) cholesterol.
Purpose of the Study:
- To investigate the prognostic value of apolipoprotein A-I (apoA-I) and apolipoprotein A-II (apoA-II) levels.
- To determine if apoA-I and apoA-II can predict subsequent coronary events in non-diabetic men post-AMI.
Main Methods:
- A cohort of 178 non-diabetic men after AMI was studied.
- Serum levels of apoA-I and apoA-II were measured.
- Patients were followed for a mean of 4 years for major coronary events.
Main Results:
- No significant difference in apoA-I or apoA-II levels was observed between patients with and without subsequent coronary events.
- These findings remained consistent across subgroups, including those receiving interventions.
Conclusions:
- Serum levels of apolipoprotein A-I and A-II are not reliable predictors of coronary events in the early years following acute myocardial infarction.
- Further research may be needed to identify other effective prognostic biomarkers for post-AMI patients.
Abstract:
The implications of apolipoproteins A-I and A-II for the prognosis of 178 non-diabetic men after acute myocardial infarction were studied. During a mean follow-up period of 4 years, one or more "coronary events" (nonfatal myocardial infarction, fatal coronary heart disease, coronary artery bypass graft surgery, deterioration of exercise ECG) were recorded in 37 patients. Serum levels of apolipoproteins A-I and A-II did not discriminate between patients with and without coronary events. This applied to the entire sample as much as to subgroups defined by presence or absence of interventions (coronary artery bypass graft surgery, long-term therapy with beta-blockers or lipid-lowering drugs). We conclude that coronary events in the first years after myocardial infarction cannot be predicted by apolipoprotein A-I or A-II levels.